Amgen Inc.
AMGN
$253.59
-$1.29-0.51%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/27/2023
-
Tickeron - Stocks
1/27/2023
-
Ticker Report
1/26/2023
-
Zacks Investment Research
1/26/2023
-
PR Newswire
1/26/2023
-
Zacks Investment Research
1/26/2023
-
Fool.com Headlines
1/26/2023
-
Tickeron - Stocks
1/25/2023
-
Stock Options Channel
1/25/2023
-
Dividend Channel
1/25/2023
-
Zacks Investment Research
1/25/2023
-
Zacks Investment Research
1/25/2023
-
Ticker Report
1/25/2023
-
Fool.com Headlines
1/25/2023
-
Zolmax
1/24/2023
-
InvestorPlace
1/24/2023
-
Ticker Report
1/24/2023
-
Zolmax
1/24/2023
-
Zolmax
1/24/2023
-
Ticker Report
1/23/2023
-
Zolmax
1/23/2023
-
Ticker Report
1/23/2023
-
Ticker Report
1/23/2023
-
Ticker Report
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 4, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Feb 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Country
Year Founded
Business Description
Sector
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and...
more
